In Brief

European Commission’s Scientific Committee on Consumer Safety releases guidance to help firms comply with nanotech reporting and labelling requirements that go into effect next year under the recast European Cosmetics Directive. More news in brief.

Drafted by the European Commission’s Scientific Committee on Consumer Safety and released July 6, the new Guidance on the Safety Assessment of Nanomaterials is intended to help firms comply with nanotechnology requirements under the 2009 recast of the European Cosmetics Directive Also see "Parliament Passes Updated Cosmetics Directive For All 27 European States" - HBW Insight, 30 March, 2009.. Starting in January 2013, firms will be required to inform the EC of all cosmetic products that contain nanomaterials six months before they are placed on the market and to provide the regulator with safety-assessment data. The guidance includes a checklist to help firms ensure that they are meeting data-reporting obligations, according to the notice. Also under the recast directive, which enters into force in July 2013, cosmetic products containing nanomaterials will be required to be labelled as such, with the name of the ingredient followed by “nano” in brackets. The EC says its nanotech guidance is likely to be updated regularly, the EC says. At its last meeting, the Cosmetic Ingredient Review Expert Panel debated its role in assessing the safety of nanomaterials in cosmetics Also see "CIR Panel Grapples With Safety Review Protocol For Nanomaterials" - HBW Insight, 18 June, 2012..

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

P&G: Innovation, Pricing ‘Short-Term Levers’ For Tariffs Adding Up To $1.5Bn In Costs Annually

 

The Procter & Gamble Company is working to mitigate the impact of tariffs, which will add up to $1.5bn in costs annually. The firm has lowered its fiscal 2025 outlook.

Access To Discounted Naloxone In California Expanded To All Consumers With Potential Need

 
• By 

After the product’s initial launch in May 2024, California’s government has now expanded the availability of its CalRx-branded generic OTC Narcan to all of its citizens.

US Consumer Health Market People News: CHPA Foundation Contest, Celsius And AdvoCare Hires

 

CHPA Health In Hand Foundation accepting nominations for 2025 US Self-Care Marketing Awards; Celsius hires former PepsiCo as president/COO and closes $1.8bn acquisition of energy drink competitor Alani; and AdvoCare adds John Peirano as integrated marketing VP after hiring Kathy Blosser supply chain VP.